Company Filing History:

5 out of 1,451

Sanofi

Years Active: 1985-1994

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5276036 - 3-(N-azabicycloalkyl)aminopyridazine derivatives and pharmaceutical (1994-01-04),

2. 4631280 - Pyridazine derivatives having a psychotropic action, and medicaments in (1986-12-23),

3. 4602015 - 2-piperazinopyrimidine salt and pharmaceutical compositions containing it (1986-07-22),

4. 4565814 - Pyridazine derivatives having a psychotropic action and compositions (1986-01-21),

5. 4540696 - 1-Piperazinyl 4-phenylquinazoline compounds having antidepressant (1985-09-10),

6. 4524070 - Aminated derivatives of pyridazine substituted in 6 position by a (1985-06-18),

7. 4508720 - Amino derivatives of pyridazine, and compositions thereof for the (1985-04-02),

Title: The Innovative Contributions of Jean-Paul Kan

Introduction

Jean-Paul Kan, a prominent inventor based in Clapiers, France, has made significant contributions to the field of pharmacology. With an impressive portfolio of 7 patents, his work primarily focuses on the development of novel compounds with psychotropic properties. His inventions reflect a dedication to advancing medical science and improving therapeutic options.

Latest Patents

Kan's latest patents showcase his innovative spirit and expertise. Among his notable inventions is the patent for 3-(N-azabicycloalkyl)aminopyridazine derivatives. This innovation details the formula for 3-aminopyridazine derivatives, which possess pharmacological significance. Additionally, he has patented pyridazine derivatives that have been substituted at the 4-position by a cyano group, emphasizing their potential as medicaments. The process for preparing these derivatives further highlights his commitment to enhancing medicinal chemistry.

Career Highlights

Throughout his career, Jean-Paul Kan has collaborated with leading companies in the pharmaceutical industry. Notably, he has worked with Sanofi and Elf Sanofi, where his research and development efforts have contributed to the advancement of various therapeutic agents. His innovative mindset and scientific acumen have positioned him as a sought-after inventor in his field.

Collaborations

In his professional journey, Kan has partnered with esteemed colleagues such as Kathleen Biziere and Camille-Georges Wermuth. These collaborations have enriched his research endeavors and facilitated the exchange of ideas, further driving innovation in the realm of pharmaceuticals.

Conclusion

Jean-Paul Kan's contributions as an inventor reflect a profound commitment to improving healthcare through innovative solutions. With several patents to his name, his work continues to influence the pharmaceutical landscape, paving the way for future advancements in medicine. His legacy as an inventor is marked by his creative approaches to developing new therapeutic compounds that hold the promise of enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.